Methyldopa
Active substance: methyldopa
TABLET · METHYLDOPA 250 mg/1
United StatesActive
Marketing holder: Rising Pharma Holdings, Inc.
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 2
Composition
- METHYLDOPA · 250 mg/1
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| RU 4 |
|
Import and control
Control by country
- Russiaprescription only
Source: GRLS (Russian state register) · record 01a120c3-430c-7758-91a7-6cd23974697e,01a120c4-2bab-77a0-b48e-6a36809b7c06;count=2 · valid from 2026-10-09 · verified 2026-10-09
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-97df-71ae-b342-75122daf7d50,01a12094-349d-7d06-92bc-b8e3b23d4a94,01a12096-9753-7d6d-b716-2b33e39b2ed8,01a12098-f0bf-7f9d-bdad-3cecc340142b;count=4 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 64980-571
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- ORAL
Sources
- product · openFDA NDC · 64980-571 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 64980-571 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 64980-571 · Verified 2026-10-09 · open in source